ES2188766T3 - Composicion farmaceutica que contiene lamotrigina. - Google Patents

Composicion farmaceutica que contiene lamotrigina.

Info

Publication number
ES2188766T3
ES2188766T3 ES96923914T ES96923914T ES2188766T3 ES 2188766 T3 ES2188766 T3 ES 2188766T3 ES 96923914 T ES96923914 T ES 96923914T ES 96923914 T ES96923914 T ES 96923914T ES 2188766 T3 ES2188766 T3 ES 2188766T3
Authority
ES
Spain
Prior art keywords
pct
pharmaceutical composition
composition containing
lamotrigine
containing lamotrigine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96923914T
Other languages
English (en)
Inventor
Alison Green Floyd
Sunil Jain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Application granted granted Critical
Publication of ES2188766T3 publication Critical patent/ES2188766T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

UNA FORMULA LIOFILIZADA DE LAMOTRIGINE PREPARADA AL LIOFILIZAR UNA SOLUCION ACUOSA ESTERIL CONGELADA DE LAMOTRIGINE MESILATO CUYO PH ESTA COMPRENDIDO ENTRE 2,5 Y 4.
ES96923914T 1995-06-23 1996-06-20 Composicion farmaceutica que contiene lamotrigina. Expired - Lifetime ES2188766T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9512854.2A GB9512854D0 (en) 1995-06-23 1995-06-23 Novel formulation

Publications (1)

Publication Number Publication Date
ES2188766T3 true ES2188766T3 (es) 2003-07-01

Family

ID=10776584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96923914T Expired - Lifetime ES2188766T3 (es) 1995-06-23 1996-06-20 Composicion farmaceutica que contiene lamotrigina.

Country Status (12)

Country Link
US (1) US5942510A (es)
EP (1) EP0833640B1 (es)
JP (1) JPH11507936A (es)
AT (1) ATE228844T1 (es)
AU (1) AU6415796A (es)
DE (1) DE69625200T2 (es)
DK (1) DK0833640T3 (es)
ES (1) ES2188766T3 (es)
GB (1) GB9512854D0 (es)
PT (1) PT833640E (es)
SI (1) SI0833640T1 (es)
WO (1) WO1997000681A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
JP2002541215A (ja) * 1999-04-09 2002-12-03 ユーロ−セルティック エス． ア． ナトリウムチャネル遮断薬組成物およびその使用
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
EP1390355A4 (en) 2001-02-27 2005-02-23 Teva Pharma NEW CRYSTALLINE FORMS OF LAMOTRIGIN AND METHOD FOR THE PRODUCTION THEREOF
NZ531586A (en) * 2001-09-03 2005-09-30 Newron Pharm Spa Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
ATE357217T1 (de) * 2002-04-23 2007-04-15 Teva Pharma Pharmazeutische zusammensetzung enthaltend lamotrigine-partikel mit definierter morphologie
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
PT1809271E (pt) * 2004-09-10 2010-08-30 Newron Pharm Spa Utilização de (halogenobenziloxi)benzilamino-propanamidas para o fabrico de medicamentos activos como moduladores selectivos dos canais de sódio e/ou de cálcio
WO2007011743A2 (en) 2005-07-14 2007-01-25 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US20120142919A1 (en) * 2006-08-02 2012-06-07 Medichem, S.A. Method for synthesizing lamotrigine
US8486927B2 (en) * 2007-11-09 2013-07-16 Thar Pharmaceuticals Crystalline forms of lamotrigine
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SG182485A1 (en) * 2010-01-15 2012-08-30 Lithera Inc Lyophilized cake formulations
CN103269693A (zh) 2010-11-24 2013-08-28 利赛拉公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
CN104940128A (zh) * 2015-05-31 2015-09-30 黑龙江佰彤儿童药物研究有限公司 一种拉莫三嗪口服液体制剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
FR2699077B1 (fr) * 1992-12-16 1995-01-13 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes.
FR2702148B1 (fr) * 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
FR2702149B1 (fr) * 1993-06-03 1995-04-07 Rhone Poulenc Rorer Sa Application de la lamotrigine dans le traitement du neuro-sida.
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
SI9420052B (sl) * 1993-09-15 2004-02-29 Syntex (U.S.A.) Inc. Kristalni brezvodni mikofenolatni mofetil in njegova intravenozna formulacija
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
GB9426448D0 (en) * 1994-12-30 1995-03-01 Wellcome Found Process
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation

Also Published As

Publication number Publication date
EP0833640B1 (en) 2002-12-04
ATE228844T1 (de) 2002-12-15
DE69625200D1 (de) 2003-01-16
DE69625200T2 (de) 2003-08-21
GB9512854D0 (en) 1995-08-23
JPH11507936A (ja) 1999-07-13
AU6415796A (en) 1997-01-22
DK0833640T3 (da) 2003-03-24
WO1997000681A1 (en) 1997-01-09
SI0833640T1 (en) 2003-08-31
US5942510A (en) 1999-08-24
PT833640E (pt) 2003-04-30
EP0833640A1 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
ES2188766T3 (es) Composicion farmaceutica que contiene lamotrigina.
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
PT979244E (pt) Derivados de ciclosporina, sua preparacao e composicoes farmaceuticas que os contem
FI951468A (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
BR9609847A (pt) Derivados de N-(4-Benzila-substituída)-2-aminolactam
ES2191099T3 (es) Derivados de hidantoina como productos intermedios para principios activos farmaceuticos.
ES2132383T3 (es) Inhibidores de proteasa hiv.
DK0891341T3 (da) 1,3,4-Oxadiazinderivater samt deres anvendelse som pesticider
MY121604A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
BR9608472A (pt) Uso de um composto preparação farmacêutica e processo para uso na profilaxa e/ou tratamento de sintomas dispépticos
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem
BR0009285A (pt) Derivados de avermectina
DE69910787D1 (de) Neuartige, pharmazeutisch aktive verbindung
BR9608038A (pt) Fenilamidinas substituídas compostos que contêm estes medicamentos e processo para sua preparação
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ATE190316T1 (de) Peptid-aldehydderivate als antikoagulierende mittel
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
FR2700116B1 (fr) Application d'anticonvulsivants comme radioprotecteurs.
MX9101421A (es) Composiciones farmaceuticas que comprenden naproxen y sodio de naproxen e hidrocloruro de pseudoefedrina.